David Schwartz is Of Counsel to Saxena White and focuses his practice on event-driven and special situation litigation using legal strategies to enhance clients’ investment returns. His extensive experience includes prosecuting, as well as defending against, securities and corporate governance actions for an array of domestic and international clients, including hedge funds, merger arbitrageurs, retail investors, pension funds, mutual funds, and asset management companies.
Mr. Schwartz has played a pivotal role in some of the largest securities class action and corporate governance cases in recent years achieving over $200 million in settlements in 2022 alone, including:
- In re CannTrust, Inc. Securities Litigation ($129.5 million settlement);
- In re Resideo Securities Litigation ($55 million settlement, one of the three largest in the Eighth Circuit);
- Makris, et al. v. Ionis Pharmaceuticals, Inc., et al. ($12.5 million settlement); and
- In re Mindbody, Inc. Securities Litigation ($9.75 million settlement).
Mr. Schwartz has helped secure leadership roles on behalf of his clients in some of the largest securities and Delaware breach of fiduciary duty class actions, including cases against Lordstown, Nikola, Alta Mesa, Novavax, Everbridge, QAD, and others.
Mr. Schwartz has been named a “Future Star” by Benchmark Litigation and was selected for three consecutive years to their “40 & Under Hot List,” which recognized him as one of the nation’s most accomplished attorneys. Lawdragon has recognized him as one of the country’s “500 Leading Plaintiff Financial Lawyers” and he has also been featured in Lawdragon’s Lawyer Limelight series.
Mr. Schwartz graduated cum laude from The University of Chicago in 2003 with a major in Economics and earned his Juris Doctor from Fordham University School of Law in 2008, where he served on the Urban Law Journal.